McKesson MCK reported better-than-expected second-quarter financial results on Wednesday.McKesson reported quarterly earnings of $7.07 per share which beat the analyst consensus estimate of $6.88 per share. The company reported quarterly sales of $93.70 billion which beat the analyst consensus estimate of $89.33 billion.McKesson shares gained 4.6% to close at $549.31 on Wednesday.These analysts made changes to their price targets on McKesson following earnings announcement.Baird analyst Eric Coldwell upgrad ...

McKesson Corporation (NYSE:MCK) Q2 2025 Earnings Conference Call November 6, 2024 4:30 PM ET Company Participants Rachel Rodriguez - VP of Investor Relations Brian Tyler - Chief Executive Officer Britt Vitalone - Executive Vice President and Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Kevin Caliendo - UBS Daniel Grosslight - Citi Charles Rhee - TD Cowen Brian Tanquilut - Jeffries Elizabeth Anderson - Evercore ISI Eric Percher - Nephron Research Stephanie Davis - Barclays Stephe ...

McKesson (MCK) reported $93.65 billion in revenue for the quarter ended September 2024, representing a year-over-year increase of 21.3%. EPS of $7.07 for the same period compares to $6.23 a year ago. The reported revenue represents a surprise of +4.66% over the Zacks Consensus Estimate of $89.48 billion. With the consensus EPS estimate being $6.89, the EPS surprise was +2.61%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determi ...

McKesson (MCK) came out with quarterly earnings of $7.07 per share, beating the Zacks Consensus Estimate of $6.89 per share. This compares to earnings of $6.23 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 2.61%. A quarter ago, it was expected that this prescription drug distributor would post earnings of $7.16 per share when it actually produced earnings of $7.88, delivering a surprise of 10.06%. Over the last four quarters ...

Exhibit 99.1 McKESSON CORPORATION REPORTS FISCAL 2025 SECOND QUARTER RESULTS AND RAISES FULL YEAR ADJUSTED EPS GUIDANCE IRVING, Texas, November 6, 2024 - McKesson Corporation (NYSE:MCK) today announced results for the second quarter ended September 30, 2024. Second Quarter Highlights: • Consolidated revenues of $93.7 billion increased 21%. • Earnings per diluted share of $1.87 decreased $3.05. • Adjusted Earnings per Diluted Share of $7.07 increased 13%. • McKesson announced an agreement to acquire a contro ...

McKesson Corporation (MCK) is scheduled to report second-quarter fiscal 2025 results on Nov. 6, after market close.The company delivered an earnings surprise of 10.06% in the last reported quarter. Its earnings beat estimates in three of the trailing four quarters and missed once, delivering an average surprise of 4.82%.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.MCK’s top line has been gaining primarily on the back of the rapid adoption of GLP-1 weight loss drugs as well as con ...

In its upcoming report, McKesson (MCK) is predicted by Wall Street analysts to post quarterly earnings of $6.89 per share, reflecting an increase of 10.6% compared to the same period last year. Revenues are forecasted to be $89.48 billion, representing a year-over-year increase of 15.9%. The consensus EPS estimate for the quarter has been revised 0.3% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates dur ...

McKesson (MCK) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The earnings report, which is expected to be released on November 6, 2024, might help the stock move higher if these key numbers are better than ...

McKesson (MCK) closed the most recent trading day at $508.95, moving +0.3% from the previous trading session. The stock's performance was ahead of the S&P 500's daily gain of 0.27%. Elsewhere, the Dow saw an upswing of 0.65%, while the tech-heavy Nasdaq appreciated by 0.26%.The the stock of prescription drug distributor has risen by 3.92% in the past month, leading the Medical sector's loss of 4.14% and the S&P 500's gain of 2%.Investors will be eagerly watching for the performance of McKesson in its upcomi ...

The latest trading session saw McKesson (MCK) ending at $513.67, denoting a +0.86% adjustment from its last day's close. The stock's change was more than the S&P 500's daily loss of 0.76%. Elsewhere, the Dow lost 0.75%, while the tech-heavy Nasdaq lost 1.01%.The prescription drug distributor's stock has dropped by 2.03% in the past month, exceeding the Medical sector's loss of 3.35% and lagging the S&P 500's gain of 4.31%.Investors will be eagerly watching for the performance of McKesson in its upcoming ear ...